RHEUMATOLOGY, cilt.53, sa.6, ss.1136-1141, 2014 (SCI-Expanded)
Objectives. Behcet's disease (BD) can be life threatening and may be refractory to corticosteroids and immunosuppressives. There has been some experience with haematopoietic stem cell transplantation (HSCT) in BD either for severe, refractory disease or for a haematological condition. The objectives of this study were to describe a BD patient undergoing HSCT and to evaluate the outcomes of BD patients who underwent HSCT.